FDA to permit retail pharmacies to supply abortion drugs

The Meals and Drug Administration will permit retail pharmacies to dispense abortion medicine to ladies who've a prescription for the primary time.

Below the brand new regulatory change, pharmacies that grow to be licensed can provide mifepristone, which is used with misoprostol to finish being pregnant, to sufferers who've acquired a prescription from a professional well being supplier, a transfer that can broaden entry to the medicine. Beforehand, the FDA had solely allowed abortion medicine to be prescribed and allotted solely by clinics, medical workplaces, hospitals, or beneath the supervision of an authorized well being supplier.

HOUSE DEMS FAULT FDA'S 'ATYPICAL' REVIEW PROCESS FOR BIOGEN'S ALZHEIMER'S DRUG

"At this time’s FDA announcement expands entry to drugs which are important for reproductive autonomy and is a step in the proper route that's particularly wanted to extend entry to abortion care," mentioned Evan Masingill, the CEO of GenBioPro, the producer of generic mifepristone, in an announcement to the Washington Examiner. "GenBioPro seems to be ahead to working with prescribers and pharmacies to extend entry to medical abortion look after all folks."

The FDA had beforehand mentioned in December 2021 that it might not implement a rule that required folks to get the primary of the 2 medication in particular person at a medical workplace or clinic, permitting abortion medicine to be despatched via the mail in the course of the COVID-19 pandemic.